A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Titel:
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Auteur:
Dunn, L.A. Fury, M.G. Xiao, H. Baxi, S.S. Sherman, E.J. Korte, S. Pfister, C. Haque, S. Katabi, N. Ho, A.L. Pfister, D.G.